Europe — EMA

Onkotrone (Mitoxantrone Hydrochloride)

Mitoxantrone Hydrochloride, the active ingredient in Onkotrone, is an antineoplastic presented as a unknown/unknown for unknown use. It treats certain types of cancer in adult patients.

Mitoxantrone Hydrochloride

Request sourcing

Pack/s

What is Mitoxantrone Hydrochloride?

Mitoxantrone Hydrochloride, the active ingredient in Onkotrone, is an antineoplastic presented as a unknown/unknown for unknown use. It treats certain types of cancer in adult patients. GNH USA supplies Onkotrone as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

What is Mitoxantrone Hydrochloride used for?

Mitoxantrone Hydrochloride acts as a DNA‑intercalating agent and the following clinical uses are among the approved indications: - Acute acute : ... … .... … … … … … … … … … ... … … ... ... . - .... ... ...

What are the side effects of Mitoxantrone Hydrochloride?

...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →